Why is Emmessar Biotech falling/rising?

As of 12-September, Emmessar Biotech & Nutrition Ltd is experiencing a decline in its stock price, currently at Rs 26.41, which reflects a decrease of Rs 0.98 or 3.58%. The stock has been underperforming significantly, having fallen for the last three days with a total decline of 4.38% during this period. It is also trading below all key moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, just 2.31% above Rs 25.8, and has seen a drastic drop in delivery volume, which fell by 72.89% compared to the 5-day average. The stock's year-to-date performance shows a staggering decline of 42.96%, further emphasizing its struggles in the market.
In the broader market context, Emmessar Biotech's short-term performance is notably worse than the benchmark Sensex, which has gained 1.48% over the past week while Emmessar has lost 0.71%. Over the past month, the stock has decreased by 4.10%, contrasting with the Sensex's increase of 2.08%. This underperformance is compounded by a lack of positive factors in the available data, suggesting that investor sentiment is weak, and participation in the stock is declining. Overall, the combination of poor stock performance, declining investor interest, and unfavorable comparisons to the benchmark indicates a challenging environment for Emmessar Biotech.